Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
C1orf187 Blocking Peptide (AC1235)
Cat.#: ACPP-1235
Specifications
Despition C1orf187 Blocking Peptide for Immunodepletion, Immunocompetition SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1739 Human SYT3 Protein (AC1739) 5 µg inquiry ACPP-1792 Rat CALB1 Protein (AC1792) 1 µg inquiry ACPP-1076 Synaptophysin Blocking Peptide (AC1076) 250 µg inquiry ACPP-1690 Human PDE6H Protein (AC1690) 2 µg inquiry ACPP-1268 Human LGALS3 Protein (AC1268) 10 µg inquiry ACPP-1132 Recombinant Human Calbindin Protein (AC1132) 25 µl inquiry ACPP-1071 Visfatin Blocking Peptide (AC1071) 250 µg inquiry ACPP-1447 Human CANX Protein (AC1447) 10 µg inquiry ACPP-1118 Human Insulin (Active) (AC1118) 25 mg inquiry ACPP-1315 GTP cyclohydrolase 1 Blocking Peptide (AC1315) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket